ESG

With backing from CPG giants, the creatine gummy maker plans to use its new $20M funding to make the supplement a daily wellness staple for everyone.

A new 73-bed facility in Newark will create 122 jobs, expand services for an aging population, and set a new standard for rehabilitation in the region.

Christine Cooper's appointment to the SIIA board places a fierce cost-containment advocate at the heart of policy-making for self-insured health plans.

New research shows government digital services are widely available but rarely used, as legacy systems and low adoption create an invisible barrier to efficiency.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Soaring diesel prices are pushing Canada's truckers to the brink, threatening a fragile recovery and signaling higher costs for consumers on everything.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

Shanghai names Sanyou Bio a top municipal tech center, validating its AI-powered antibody library that's reshaping global drug R&D and fueling regional innovation.

The biotech firm's oversubscribed funding round will accelerate its universal flu shot and a diverse pipeline targeting cancer, malaria, and Alzheimer's.

In a strategic move to dominate the AI infrastructure boom, AVAIO Digital has hired industry pioneer Jason Norado to execute its multi-gigawatt expansion.

A new survey reveals a chasm between patriotic slogans and spending, as Canadian small businesses battle rising costs, cash flow crunches, and fading hope.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

Phase 2 data for HRS/BHB-1893 show rapid efficacy and a simplified regimen, signaling a potential new era for treating hypertrophic cardiomyopathy.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

Beyond apparel, Anthropologie and FARM Rio's new home line is a strategic play on maximalism, sustainability, and the power of a decade-long partnership.

A new pocket-sized, AI-powered ultrasound aims to revolutionize prenatal care in Africa, putting life-saving diagnostics into the hands of local caregivers.

German CDMO Vetter wins a prestigious, client-voted award, underscoring its pivotal role and massive €2 billion investment in the world of injectable biologics.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

A new partnership aims to merge digital brain therapies with functional foods, targeting Japan and Southeast Asia's rapidly growing elderly populations.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.